Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL.
Nature. 2022 Sep;609(7926):369-374. doi: 10.1038/s41586-022-05140-y. Epub 2022 Aug 31.
Nature. 2022.
PMID: 36045296
Free PMC article.
Clinical Trial.